Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance

Zhao, Zhen, Sagare, Abhay P, Ma, Qingyi, Halliday, Matthew R, Kong, Pan, Kisler, Kassandra, Winkler, Ethan A, Ramanathan, Anita, Kanekiyo, Takahisa, Bu, Guojun, Owens, Nelly Chuqui, Rege, Sanket V, Si, Gabriel, Ahuja, Ashim, Zhu, Donghui, Miller, Carol A, Schneider, Julie A, Maeda, Manami, Maeda, Takahiro, Sugawara, Tohru, Ichida, Justin K, Zlokovic, Berislav V·2015·Nature Neuroscience
DOI 10.1038/nn.4025

Cited by (410)

Items 401–410 of 410

  1. Biased multi-view contrastive learning with attentive masking for spatial transcriptomic analysis
    Laiyi Fu, Wenkai Cui, Yuehua Chen, Danyang Wu, Han Sun · 2026 · Briefings in Bioinformatics
  2. A Multi-Context Regulome-Wide Association Atlas for Genetic Studies of Aging Brain Disorders
    Chunming Liu, Anqi Wang, Hao H. Sun, Kaixuan Luo, Sheng Qian, Yining Li, Daniel C. Nachun, Xin He, Philip L. De Jager, David A. A Bennett et al. · 2026 · medRxiv
  3. Circulatory pro‐CTSD binds brain endothelial LRP1 to trigger its lysosomal degradation leading to amyloid beta clearance deficit in Alzheimer's disease mice
    Zhi-Jun Li, Zhao Yang, Dan Zhao, Yihua Qiu, Wen‐Yu Wan, Zeng-Kang Huang, Li Tian, Rui‐Qun Qi, Hongguang Liu, Yuehua Chen et al. · 2026 · Alzheimer s & Dementia
  4. Integration of multi-omics and artificial intelligence for therapeutic insights in Alzheimer's disease: A comprehensive review
    Tamilarasi Sambu Periyasamy, Nishu Sekar, Hariprasath Lakshmanan · 2026 · Journal of Alzheimer s Disease
  5. Proteomics Reveals Blood−Brain Barrier Membrane Protein Remodeling in Amyloid-β Pathology
    Jooseppi Hyvärinen, Rositsa Todorovska, Maria del Pilar Palacios, Mikko Gynther, Alexey Afonin, Marko Lehtonen, Seppo Auriola, Liudmila Saveleva, Katja M. Kanninen, Gert Fricker et al. · 2026 · Molecular Pharmaceutics
  6. INPP5D/SHIP1 in Alzheimer’s Disease: Linking Microglial Substrate Handling to Neuroinflammation and Neurovascular Dysfunction
    Junxiang Xu, Yijin Chang, Dong Liu, Changsheng Chen · 2026 · Neurology International
  7. A silent RAGE: The inflammatory pathway to dementia in Parkinson’s disease
    Daniel Oppermann Peixoto, Juciano Gasparotto, Olajide Raymond Ojo, Olayemi Philemon Aro, Umin-Awaji Sunday Godswill, Luiza Franco de Abreu, Luana Carneiro Lopes, J. C. Fonseca Moreira, Daniel Pens Gelain · 2026 · Ageing Research Reviews
  8. Disease stage-sensitive MFSD2A-caveolae axis insigates hippocampal blood–brain barrier disruption in Alzheimer’s disease
    Yiyi Zhu, Danjie Yang, jiayi chen, qi wang, Weijie Xiong, jingyu wang, hui chen, Alexei Verkhratsky, Chenju Yi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Cross-cohort transfer of clinical Alzheimer’s EEG signatures to cognitively healthy APOE-ε4 and PICALM rs3851179 risk carriers using differentiable logic gate networks
    Shyamal Y. Dharia, Camilo E. Valderrama, Stephen D. Smith · 2026 · Computers in Biology and Medicine
  10. A cell-type-directed drug repurposing framework for Alzheimer's disease subtypes
    Yaqiao Li, Xinyu Tang, Carlota Pereda Serras, Alice Tang, Tomiko Oskotsky, Marina Sirota · 2026 · Acta Pharmaceutica Sinica B